Salignostics

Salignostics is a pioneering biotechnology research company specializing in the development of innovative saliva-based rapid diagnostic tests (RDT). Utilizing a cutting-edge lateral flow immunoassay platform, Salignostics is transforming in-vitro diagnostics. The company's platform features a comprehensive suite of technologies designed to amplify saliva, overcoming various chemical and biological obstacles to make it a readily detectable body fluid.

Located at Jerusalem Bio-Park, Jerusalem, Jerusalem 91120, IL, Salignostics is dedicated to advancing diagnostic capabilities through groundbreaking research and development. By converting saliva from a traditionally non-detectable fluid into a reliable diagnostic medium, Salignostics is setting new standards in the biotechnology industry. The company is committed to delivering accurate, efficient, and accessible diagnostic solutions.

Salignostics continues to push the boundaries of biotechnology, driving innovation and enhancing healthcare outcomes. We invite the management team at Salignostics to create a customized and exclusive company showcase and product listing on our platform, highlighting your contributions to the field.